Stephen Feider - 27 Feb 2026 Form 4/A - Amendment Insider Report for Beta Bionics, Inc. (BBNX)

Role
Chief Financial Officer
Signature
/s/ Stephen Feider
Issuer symbol
BBNX
Transactions as of
27 Feb 2026
Net transactions value
$0
Form type
4/A - Amendment
Filing time
13 Mar 2026, 16:15:14 UTC
Date Of Original Report
03 Mar 2026
Previous filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feider Stephen Chief Financial Officer C/O BETA BIONICS, INC., 11 HUGHES, IRVINE /s/ Stephen Feider 13 Mar 2026 0002048588

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBNX Employee Stock Option (right to buy) Award +110,342 $0.000000* 110,342 27 Feb 2026 Common Stock 110,342 $12.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026.